Web Analytics

3 Latest Announced Rounds

  • $7,500,000
    Seed

    2 Investors

    Software Development
    Nov 21st, 2024
  • $6,000,000
    Series A

    1 Investors

    Transportation, Logistics, Supply Chain and Storage
    Nov 21st, 2024
  • $30,000,000
    Unknown

    1 Investors

    Financial Services
    Nov 21st, 2024
$1,264.20M Raised in 73 Funding Rounds in the past 7 Days - View All

Funding Round Profile

Passkey Therapeutics

start up
United States - Cambridge, MA
  • 22/10/2024
  • Seed
  • $20,000,000

Passkey Therapeutics is pioneering a new class of medicines, Synergistic Multifunctional Therapeutics or SMThs, designed to address complex diseases by targeting rare combinations of proteins that work together. Using its proprietary Locksmith platform, the company is advancing programs across multiple therapeutic areas to create new options for patients with common, hard-to-treat conditions.


Related People

Bruce BeutelCo Founder

Bruce Beutel United States - Greater Boston

Leadership experience in novel therapeutics and platform research, business development, and company creation. Focused on strategy, vision, team building and value creation at the interface of science and business, particularly for seed through Series A stage biotech.